Literature DB >> 30385075

Neuropathic pain: Definition, assessment and epidemiology.

D Bouhassira1.   

Abstract

Neuropathic pain has been a very active and productive clinical research field over the last 15 years. Studies have concerned multiple aspects of these complex chronic pain syndromes including their very definition, the elaboration of new diagnostic algorithms, the development of specific tools for their screening and measurement and their epidemiology. In this review, we summarize these recent evolutions that have impacted the way these pain syndromes are conceptualized and managed both in daily practice and in the clinical research setting.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Assessment; Chronic pain; Epidemiology; Neuropathic pain; Pain

Mesh:

Year:  2018        PMID: 30385075     DOI: 10.1016/j.neurol.2018.09.016

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  48 in total

Review 1.  Topical clonidine for neuropathic pain in adults.

Authors:  Wojciech T Serednicki; Anna Wrzosek; Jaroslaw Woron; Jaroslaw Garlicki; Jan Dobrogowski; Joanna Jakowicka-Wordliczek; Jerzy Wordliczek; Renata Zajaczkowska
Journal:  Cochrane Database Syst Rev       Date:  2022-05-19

2.  Occurrence of Lymphangiogenesis in Peripheral Nerve Autografts Contrasts Schwann Cell-Induced Apoptosis of Lymphatic Endothelial Cells In Vitro.

Authors:  Carina Hromada; Jaana Hartmann; Johannes Oesterreicher; Anton Stoiber; Anna Daerr; Barbara Schädl; Eleni Priglinger; Andreas H Teuschl-Woller; Wolfgang Holnthoner; Johannes Heinzel; David Hercher
Journal:  Biomolecules       Date:  2022-06-12

Review 3.  Diagnosis and Management of Pain in Parkinson's Disease: A New Approach.

Authors:  Veit Mylius; Jens Carsten Möller; Stephan Bohlhalter; Daniel Ciampi de Andrade; Santiago Perez Lloret
Journal:  Drugs Aging       Date:  2021-07-05       Impact factor: 3.923

4.  Fe3O4@Polydopamine-Labeled MSCs Targeting the Spinal Cord to Treat Neuropathic Pain Under the Guidance of a Magnetic Field.

Authors:  Meichen Liu; Weijia Yu; Fuqiang Zhang; Te Liu; Kai Li; Meng Lin; Ying Wang; Guoqing Zhao; Jinlan Jiang
Journal:  Int J Nanomedicine       Date:  2021-05-11

5.  T cell transgressions: Tales of T cell form and function in diverse disease states.

Authors:  Kevin M Harris; Madison A Clements; Andrew J Kwilasz; Linda R Watkins
Journal:  Int Rev Immunol       Date:  2021-06-21       Impact factor: 5.078

6.  The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

Authors:  Rebecca Speltz; Mary M Lunzer; Sarah S Shueb; Eyup Akgün; Rachelle Reed; Alex Kalyuzhny; Philip S Portoghese; Donald A Simone
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

7.  Adjuvant administration of hypertonic saline in lumbar epidural intervention may be associated with successful response in patients with probable neuropathic radicular pain Screened by Douleur Neuropathique 4.

Authors:  Yongsoo Lee; Sunmin Kim; Jin-Woo Shin; Jeong-Gil Leem; Seong-Soo Choi
Journal:  Int J Med Sci       Date:  2021-05-17       Impact factor: 3.738

8.  Screening and Identification of Key Genes, Pathways, and Drugs Associated with Neuropathic Pain in Dorsal Horn: Evidence from Bioinformatic Analysis.

Authors:  Xiao Yang; Lin Zhu; Bingcheng Zhao; Jingjuan Hu; Fan Deng; Shaohui Lei; Zhi-Wen Yao; Kexuan Liu
Journal:  J Pain Res       Date:  2021-06-16       Impact factor: 3.133

Review 9.  Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.

Authors:  Kinga Sałat
Journal:  Pharmacol Rep       Date:  2020-05-11       Impact factor: 3.024

10.  Application and Clinical Effectiveness of Antibiotic-Loaded Bone Cement to Promote Soft Tissue Granulation in the Treatment of Neuropathic Diabetic Foot Ulcers Complicated by Osteomyelitis: A Randomized Controlled Trial.

Authors:  Regis Ernest Mendame Ehya; Hao Zhang; Baiwen Qi; Aixi Yu
Journal:  J Diabetes Res       Date:  2021-07-13       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.